StockData

ProPhase Labs, Inc. (PRPH) stock

PRPHOTCPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 19, 2026Score 0/30
$0.01−0.00 (-6.16%)

Close on Oct 19, 2026Market cap $119.68KP/E –Yield –

ProPhase Labs cash

Cash and short-term investments held at the end of each period.

ProPhase Labs's cash was $20.00K at Jun 30, 2026. For fiscal 2025 it was $90.00K, down 87.1% from the year before. Over ten years it grew -25.3% a year on average. The highest annual figure on record is $21.94M in fiscal 2017.

Annual cash

PeriodPeriod endValueChange
FY2025Dec 31, 2025$90.00K-87.1%
FY2024Dec 31, 2024$700.00K-86.8%
FY2023Dec 31, 2023$5.30M-69.6%
FY2022Dec 31, 2022$17.44M0.0%
FY2021Dec 31, 2021$17.44M+106.2%
FY2020Dec 31, 2020$8.46M+521.7%
FY2019Dec 31, 2019$1.36M-83.5%
FY2018Dec 31, 2018$8.24M-62.4%
FY2017Dec 31, 2017$21.94M+4874.6%
FY2016Dec 31, 2016$441.00K-73.5%
FY2015Dec 31, 2015$1.66M-43.1%
FY2014Dec 31, 2014$2.93M+78.6%
FY2013Dec 31, 2013$1.64M+186.4%
FY2012Dec 31, 2012$572.00K-89.7%
FY2011Dec 31, 2011$5.54M-32.7%
FY2010Dec 31, 2010$8.23M-35.7%
FY2009Dec 31, 2009$12.80M+7.1%
FY2008Dec 31, 2008$11.96M–

Quarterly cash

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$20.00K-88.3%
Q1 FY2026Mar 31, 2026$31.00K-64.8%
Q4 FY2025Dec 31, 2025$90.00K-87.1%
Q3 FY2025Sep 30, 2025$405.00K-19.5%
Q2 FY2025Jun 30, 2025$171.00K-90.4%
Q1 FY2025Mar 31, 2025$88.00K-92.9%
Q4 FY2024Dec 31, 2024$700.00K-86.8%
Q3 FY2024Sep 30, 2024$503.00K-84.6%
Q2 FY2024Jun 30, 2024$1.78M-80.4%
Q1 FY2024Mar 31, 2024$1.23M-92.1%
Q4 FY2023Dec 31, 2023$5.30M-69.6%
Q3 FY2023Sep 30, 2023$3.27M-87.7%
Q2 FY2023Jun 30, 2023$9.10M-66.9%
Q1 FY2023Mar 31, 2023$15.56M-47.0%
Q4 FY2022Dec 31, 2022$17.44M0.0%
Q3 FY2022Sep 30, 2022$26.48M+16.9%
Q2 FY2022Jun 30, 2022$27.50M-23.1%
Q1 FY2022Mar 31, 2022$29.35M-19.1%
Q4 FY2021Dec 31, 2021$17.44M+106.2%
Q3 FY2021Sep 30, 2021$22.65M+84.7%
Q2 FY2021Jun 30, 2021$35.77M+508.8%
Q1 FY2021Mar 31, 2021$36.26M+2259.0%
Q4 FY2020Dec 31, 2020$8.46M+521.7%
Q3 FY2020Sep 30, 2020$12.26M+159.4%
Q2 FY2020Jun 30, 2020$5.88M+2.5%
Q1 FY2020Mar 31, 2020$1.54M-77.0%
Q4 FY2019Dec 31, 2019$1.36M-83.5%
Q3 FY2019Sep 30, 2019$4.73M-48.2%
Q2 FY2019Jun 30, 2019$5.73M-45.1%
Q1 FY2019Mar 31, 2019$6.68M-69.2%
Q4 FY2018Dec 31, 2018$8.24M-62.4%
Q3 FY2018Sep 30, 2018$9.14M-66.8%
Q2 FY2018Jun 30, 2018$10.44M-72.0%
Q1 FY2018Mar 31, 2018$21.71M-49.3%
Q4 FY2017Dec 31, 2017$21.94M+4874.6%
Q3 FY2017Sep 30, 2017$27.54M+7243.5%
Q2 FY2017Jun 30, 2017$37.28M–
Q1 FY2017Mar 31, 2017$42.80M–
Q4 FY2016Dec 31, 2016$441.00K–
Q3 FY2016Sep 30, 2016$375.00K–

More ProPhase Labs figures

See a number that looks wrong?